Pharmacovigilance notifications

SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate actions, if and when needed, in order to evaluate and update all information regarding the benefit-risk of our products.

 

 
Subject of the inquiry*
E-MAIL*
Description of the inquiry
Informativa sulla privacy

I confirm that I have read the privacy statement and on the basis of that:

Confirmation Code* :

 
 

 
 
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

On our Social Channels

From our News Center

The sky is not the limit. Andrew Feustel, also known as "Drew" is a name that may not ring a bell if you are not in the field... At least not in the Earth's field. Drew Feustel...
 

 

04 July

SIFI, the Italian leader in ophthalmology, is pleased to announce the acquisition of Dacudoses® and Novoptine®, leading ophthalmic antiseptic brands in France with...
Follow Us!